BfR supports EFSA and ECHA with the development of European guidelines for the health assessment of endocrine disruptors

November 17, 2017

The basis of the discussion was formed by literature research and a survey conducted by the BfR among competent laboratories on the applicability and feasibility of methods in the identification of endocrine disruptors. The recommendations prepared as a result of the hearing are intended to be included as an annex to the guidelines for the health assessment of endocrine disruptors in line with the EFSA mandate. These European guidelines are currently being prepared jointly by EFSA and the European Chemicals Agency (ECHA). The results of the hearing are to be published in a scientific journal.

In July 2017, the European Commission reached an agreement with the EU member states on the criteria by which endocrine disruptors should be identified in future in the field of plant protection products and biocidal products. The EU Commission jointly commissioned the two European authorities ECHA and EFSA to prepare common guidelines as to how these hazard-based criteria can be implemented practically in the context of Regulations (EC) No. 1107/2009 and (EU) No. 528/2012. On behalf of EFSA, the BfR conducted literature research along with a survey among selected competent laboratories in order to compile information on the applicability and suitability of various methods of hormone measurements in experimental animal studies, which have to be conducted for the approval applications. This information was then discussed with the experts at the above-mentioned hearing before recommendations were prepared.

For pesticidal active substances and other chemicals harmonised scientific criteria are required for the identification of hormone-damaging substances. The BfR already published a consensus paper on this in 2016 as the scientific basis for the subsequent work of the EU authorities. On a legislative level, EU regulations are currently being established which are to be substantiated on a scientific level through guidelines for their harmonised regulatory implementation. The EU Commission has jointly commissioned EFSA and ECHA with this task. The BfR provides support to the authorities with its scientific and technical expertise by providing the corresponding EFSA work group with personnel and conducting research and surveys on the practicability of examination methods. The publication of the EFSA/ECHA guidelines is expected in spring 2018. They are to be transferred into assessment and approval practice after the corresponding regulations have been adopted by the EU Parliament and Council.
-end-
The full version of this BfR opinion is available in German on: http://www.bfr.bund.de/cm/343/BfR-unterstuetzt-EFSA-und-ECHA-bei-der-Entwicklungeuropaeischer-Leitlinien-fuer-die-gesundheitliche-bewertung-endokriner-disruptoren.pdf

BfR Federal Institute for Risk Assessment

Related Hearing Articles from Brightsurf:

Two molecular handshakes for hearing
Scientists have mapped and simulated those filaments at the atomic level, a discovery that shed lights on how the inner ear works and that could help researchers learn more about how and why people lose the ability to hear.

Proof-of-concept for a new ultra-low-cost hearing aid for age-related hearing loss
A new ultra-affordable and accessible hearing aid made from open-source electronics could soon be available worldwide, according to a study published September 23, 2020 in the open-access journal PLOS ONE by Soham Sinha from the Georgia Institute of Technology, Georgia, US, and colleagues.

Ultra-low-cost hearing aid could address age-related hearing loss worldwide
Using a device that could be built with a dollar's worth of open-source parts and a 3D-printed case, researchers want to help the hundreds of millions of older people worldwide who can't afford existing hearing aids to address their age-related hearing loss.

A promise to restore hearing
For the first time, researchers have used base editing to restore partial hearing to mice with a recessive mutation in the gene TMC1 that causes complete deafness, the first successful example of genome editing to fix a recessive disease-causing mutation.

Surprising hearing talents in cormorants
The great cormorant has more sensitive hearing under water than in air.

Veterinarians: Dogs, too, can experience hearing loss
Just like humans, dogs are sometimes born with impaired hearing or experience hearing loss as a result of disease, inflammation, aging or exposure to noise.

Older people who use hearing aids still report hearing challenges
A high proportion of older people with hearing aids, especially those with lower incomes, report having trouble hearing and difficulty accessing hearing care services, according to a study from researchers at Johns Hopkins Bloomberg School of Public Health.

Hearing class
New study finds that the class of neurons responsible for transmitting information from the inner ear to the brain is composed of three molecularly distinct subtypes.

Hearing tests on wild whales
Scientists published the first hearing tests on a wild population of healthy marine mammals.

Genes critical for hearing identified
Fifty-two previously unidentified genes that are critical for hearing have been found by testing over 3,000 mouse genes.

Read More: Hearing News and Hearing Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.